Lipidor AB
STO:LIPI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Lipidor AB
Long-Term Debt
Lipidor AB
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
Lipidor AB
STO:LIPI
|
Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Orexo AB
STO:ORX
|
Long-Term Debt
kr483.8m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
59%
|
CAGR 10-Years
0%
|
|
|
Camurus AB
STO:CAMX
|
Long-Term Debt
kr85.9m
|
CAGR 3-Years
73%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
S
|
Swedencare AB (publ)
STO:SECARE
|
Long-Term Debt
kr1.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
66%
|
CAGR 10-Years
N/A
|
|
|
I
|
Infant Bacterial Therapeutics AB
STO:IBT B
|
Long-Term Debt
kr0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
InDex Pharmaceuticals Holding AB
STO:FLERIE
|
Long-Term Debt
kr1.4m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Lipidor AB
Glance View
Lipidor AB is a drug development company. The company is headquartered in Danderyd, Stockholm. The company went IPO on 2019-09-27. The firm is focused to develop, patent and commercialize formulation concepts and technologies based on lipids. The firm develops product concepts based on AKVANO technology, which represents a dosage form that creates a lipid layer on the skin surface for effective delivery of drugs and skin care treatment. The Company’s cooperation partners include Cerbios-Pharma, which specializes in the development and manufacturing of chemical and biological active pharmaceutical ingredients (APIs), and Aurena Laboratories AB, a manufacturer of bag-on-valve aerosol sprays for the pharmaceutical and medical device industry.
